laitimes

The number of shareholders in BeiGene decreased by 2.71%, with an average shareholding of 397,500 yuan

author:Oriental Fortune Network
The number of shareholders in BeiGene decreased by 2.71%, with an average shareholding of 397,500 yuan

BeiGene disclosed in its annual report on April 27, 2024 that the number of A-share shareholders of the Company as of March 31, 2024 was 38,300, a decrease of 1,064 or 2.71% from the previous period (December 31, 2023).

The number of shareholders in BeiGene is higher than the industry average. According to Choice data, as of March 31, 2024, the average number of shareholders of listed companies in the pharmaceutical and biotechnology industry is 34,000. Among them, the number of shareholders of the company is in the range of 5,000~15,000, accounting for the highest proportion, 28.63%.

Distribution of the number of shareholders in the pharmaceutical and biological industry

The number of shareholders in BeiGene decreased by 2.71%, with an average shareholding of 397,500 yuan

Number of shareholders and share price

Since March 31, 2023, the number of shareholders of the company has decreased significantly, with a decrease of 15.27%. From March 31, 2023 to March 31, 2024, the stock price increased by 1.06%.

Number of shareholders and share price

The number of shareholders in BeiGene decreased by 2.71%, with an average shareholding of 397,500 yuan

Number of shareholders and share capital

As of March 31, 2024, the company's latest total share capital of A shares is 1.358 billion shares, of which the outstanding share capital is 115 million shares. The average number of outstanding shares held by households increased from 2,925 shares in the previous period to 3,007 shares, and the average market value of households was 397,500 yuan.

The average amount of shares held by each household

The number of shareholders in BeiGene decreased by 2.71%, with an average shareholding of 397,500 yuan

The average market value of BeiGene's households is higher than the industry average. According to Choice data, as of March 31, 2024, the average market value of A-share listed companies in the pharmaceutical and biological industry was 396,200 yuan. Among them, 25.10% of the company's households hold a circulating stock market value in the range of 130,000~255,000.

Distribution of per capita circulating market value of the pharmaceutical and biological industry

The number of shareholders in BeiGene decreased by 2.71%, with an average shareholding of 397,500 yuan

Shareholdings in Shanghai-Hong Kong Stock Connect

As of March 31, 2024, the number of shares held by SSE in BeiGene was 4,824,600 shares, accounting for 4.19% of the outstanding share capital of A shares, an increase of 394.97% from 974,700 shares in the previous period (December 31, 2023).

Shareholding chart of Shanghai-Hong Kong Stock Connect

The number of shareholders in BeiGene decreased by 2.71%, with an average shareholding of 397,500 yuan

Disclaimer: This article is based on big data and is for reference only and does not constitute any investment advice.